We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer.
- Authors
Kircher, Sheetal; Duan, Fenghai; An, Na; Gareen, Ilanan F.; Sicks, JoRean D.; Sadigh, Gelareh; Suga, Jennifer M.; Kehn, Heather; Mehan, Paul T.; Bajaj, Rajesh; Hanson, David S.; Dalia, Samir M.; Acoba, Jared D.; Yasar, Demet Gokalp; Park, Elyse R.; Wagner, Lynne I.; Carlos, Ruth C.
- Abstract
Key Points: Question: What is the trajectory of financial hardship experienced by patients treated for early-stage colorectal cancer during the 12 months after diagnosis? Findings: In this cohort study of 450 patients with colorectal cancer treated with curative intent in community settings, financial hardship was common at diagnosis and decreased over time, but some groups, such patients with low self-efficacy, unemployed individuals, or patients with government insurance, did not improve as much as their counterparts. Meaning: These findings suggest that interventions for patients with newly diagnosed cancer should focus on counseling to decrease financial worry and screening for these interventions should ensure inclusion of patients at greater risk for financial hardship. This cohort study evaluates patient-reported financial hardship during 12 months among patients with newly diagnosed colorectal cancer undergoing curative-intent therapy. Importance: The longitudinal experience of patients is critical to the development of interventions to identify and reduce financial hardship. Objective: To evaluate financial hardship over 12 months in patients with newly diagnosed colorectal cancer (CRC) undergoing curative-intent therapy. Design, Setting, and Participants: This prospective, longitudinal cohort study was conducted between May 2018 and July 2020, with time points over 12 months. Participants included patients at National Cance Institute Community Oncology Research Program sites. Eligibility criteria included age at least 18 years, newly diagnosed stage I to III CRC, not started chemotherapy and/or radiation, treated with curative intent, and able to speak English. Data were analyzed from December 2022 through April 2023. Main Outcomes and Measures: The primary end point was financial hardship, measured using the Comprehensive Score for Financial Toxicity (COST), which assesses the psychological domain of financial hardship (range, 0-44; higher score indicates better financial well-being). Participants completed 30-minute surveys (online or paper) at baseline and 3, 6, and 12 months. Results: A total of 450 participants (mean [SD] age, 61.0 [12.0] years; 240 [53.3%] male) completed the baseline survey; 33 participants (7.3%) were Black and 379 participants (84.2%) were White, and 14 participants (3.1%) identified as Hispanic or Latino and 424 participants (94.2%) identified as neither Hispanic nor Latino. There were 192 participants (42.7%) with an annual household income of $60 000 or greater. There was an improvement in financial hardship from diagnosis to 12 months of 0.3 (95% CI, 0.2 to 0.3) points per month (P <.001). Patients with better quality of life and greater self-efficacy had less financial toxicity. Each 1-unit increase in Functional Assessment of Cancer Therapy–General (rapid version) score was associated with an increase of 0.7 (95% CI, 0.5 to 0.9) points in COST score (P <.001); each 1-unit increase in self-efficacy associated with an increase of 0.6 (95% CI, 0.2 to 1.0) points in COST score (P =.006). Patients who lived in areas with lower neighborhood socioeconomic status had greater financial toxicity. Neighborhood deprivation index was associated with a decrease of 0.3 (95% CI, −0.5 to −0.1) points in COST score (P =.009). Conclusions and Relevance: These findings suggest that interventions for financial toxicity in cancer care should focus on counseling to improve self-efficacy and mitigate financial worry and screening for these interventions should include patients at higher risk of financial burden.
- Subjects
COLON tumors; RECTUM tumors; HEALTH outcome assessment; MEDICAL care costs; SURVEYS; SOCIOECONOMIC factors; SELF-efficacy; FINANCIAL stress; QUESTIONNAIRES; DESCRIPTIVE statistics; QUALITY of life; EMPLOYMENT; RESEARCH funding; ECONOMIC aspects of diseases; MARITAL status; LONGITUDINAL method
- Publication
JAMA Network Open, 2024, Vol 7, Issue 1, pe2350844
- ISSN
2574-3805
- Publication type
Article
- DOI
10.1001/jamanetworkopen.2023.50844